Atara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty
ATARA ALERT: Bragar Eagel & Squire, P.C. is Investigating Atara Biotherapeutics, Inc. on Behalf of Atara Stockholders and Encourages Investors to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Atara Biotherapeutics, Inc. with Losses of $100,000 to Contact the Firm
About · FAQs · StocksCafe © 2024 · Privacy · Terms